Human Dental Pulp Stem Cells

Human Dental Pulp Stem Cells (hDPSCs) are an elite population of mesenchymal stem cells (MSCs) derived from the perivascular niche of the dental pulp. Originating from the ectomesenchyme (cranial neural crest), hDPSCs possess a unique developmental plasticity that bridges the gap between conventional mesodermal MSCs and neural progenitor cells. This distinct lineage makes them one of the most versatile and potent tools in the current landscape of regenerative medicine and cell-based therapies.

• Exceptional Proliferative & Clonogenic Potential: hDPSCs exhibit significantly higher proliferation rates and a more robust doubling capacity compared to bone marrow-derived MSCs (BMSCs). This "youthful" cellular state allows for extensive ex vivo expansion without immediate loss of stemness, ensuring high-yield production for industrial applications.
• Superior Neuro-Odontogenic Plasticity: Given their neural crest origin, hDPSCs demonstrate a remarkable innate ability to differentiate into functional odontoblasts and neural-lineage cells (neurons and glia). This renders them an ideal substrate for treating neurodegenerative diseases, spinal cord injuries, and complex craniofacial defects.
• Potent Immunomodulatory & Angiogenic Secretome: hDPSCs exert strong paracrine effects by secreting high levels of pro-regenerative factors, including VEGF, IGF, and BDNF. Their ability to modulate T-cell responses and promote neovascularization makes them highly effective in treating inflammatory disorders and ischemic conditions.
• Ethically Sound & Minimally Invasive Access: Unlike embryonic stem cells or bone marrow aspirates, hDPSCs can be non-invasively harvested from discarded biological materials, such as third molars (wisdom teeth). This provides a continuous, ethically unburdened source of high-quality human stem cells.

Our Human Dental Pulp Stem Cells are rigorously characterized for MSC markers (CD73+, CD90+, CD105+) and multi-lineage competency. By providing a standardized, high-potency cell system, this product offers a superior alternative for pharmaceutical R&D, tissue engineering, and the development of next-generation regenerative therapeutics.